From Protein Dynamics to Precision Allosteric Discovery
AllotarX™ transforms protein conformational ensembles into actionable, selective allosteric sites, combining physics-based simulation, interpretable AI, and closed-loop validation to design safer, more precise therapeutics.
One system, continuously improving
From dynamic protein ensembles to selective, validated therapeutics in a single closed-loop system.
- Identify functional allosteric sites across ensembles
- Prioritize pockets by mechanism and druggability
- Link structure dynamics to functional outcomes
- Design selective interventions
- Validate function in biochemical and cell-based assays
- Learn from every result
discovery
engine
Prioritized regulatory sites guide modality-specific design across small molecules, macrocyclic peptides and computationally designed scaffolds.
Ensemble-guided libraries and focused candidates translate computational designs into testable interventions.
Biochemical and cell-based assays evaluate function, binding and selectivity with partner laboratories.
Every outcome, whether hit or miss, refines predictions and guides the next design cycle.
Ultra-Fast Dynamics Sampling
Maps protein conformational landscapes with over 1000× less compute than established enhanced-sampling workflows such as replica-exchange umbrella sampling applied to the same protein.
Enables end-to-end, ensemble-based drug discovery workflow.
- Unlocks target dynamics and key transition states for precision allosteric control
- Reveals cryptic sites and mechanisms underlying protein function and modulation
- Scales to large multi-chain complexes and assemblies that conventional MD cannot sample long enough to reveal functional motions.
Allosteric Discovery with Selectivity-First Design
Identifies allosteric sites with 90% benchmarked accuracy across protein ensembles.
Introduces target selectivity from the earliest stages of discovery through interpretable AI integrating druggability, dynamics, and allosteric signatures.
- Expands access to challenging targets through precise allosteric control.
- Delivers selective modulators with reduced off-target risk and improved safety potential.
- Reduces downstream attrition risk in optimization and clinical development.
Multi-Site, Multi-Modality Discovery
Designs site-specific modalities (small molecules, macrocyclic peptides, computationally designed scaffolds) tailored to the dynamic and geometric features of each regulatory site.
Integrates experimental data on binding, function, and selectivity to continuously refine predictions and guide design.
- Reduces optimization cycles and development timelines
- Expands design options through site- and modality-specific strategies
- Increases the likelihood of achieving desired functional activity and selectivity
Built on peer-reviewed science
AllotarX™ builds on methods for protein dynamics and allosteric drug discovery developed and validated by our co-founders through extensive peer-reviewed research. The platform extends this scientific foundation with proprietary advances in scale, selectivity and closed-loop learning.
Selected publications 15 papersShow listHide list
- Modulation of SARS-CoV-2 spike binding to ACE2 through conformational selectionNature Nanotechnology2025
- Predicting allosteric pockets in protein biological assemblagesBioinformatics2023
- Cooperative mechanics of PR65 scaffold underlies the allosteric regulation of the phosphatase PP2AStructure2023
- GPCR kinases generate an APH1A phosphorylation barcode to regulate amyloid-β generationCell Reports2022
- Precise druggability of the PTH type 1 receptorNature Chemical Biology2021
- ClustENMD: efficient sampling of biomolecular conformational space at atomic resolutionBioinformatics2021
- Oncogenic mutations on Rac1 affect global intrinsic dynamics underlying GTP and PAK1 bindingBiophysical Journal2021
- Allosteric interactions in the parathyroid hormone GPCR–arrestin complex formationNature Chemical Biology2020
- Intrinsic dynamics is evolutionarily optimized to enable allosteric behaviorCurrent Opinion in Structural Biology2020
- Essential site scanning analysis: A new approach for detecting sites that modulate the dispersion of protein global motionsComputational and Structural Biotechnology Journal2020
- Genome editing retraces the evolution of toxin resistance in the monarch butterflyNature2019
- RESPEC Incorporates Residue Specificity and the Ligand Effect into the Elastic Network ModelThe Journal of Physical Chemistry B2018
- Cullin neddylation may allosterically tune polyubiquitin chain length and topologyBiochemical Journal2017
- ClustENM: ENM-Based Sampling of Essential Conformational Space at Full Atomic ResolutionJournal of Chemical Theory and Computation2016
- Allosteric Dynamic Control of BindingBiophysical Journal2015

